Christine Blank, Contributing Editor

Articles

FDA reviewing safety of Parkinson’s drug

April 30, 2018

FDA is re-examining the safety of a breakthrough Parkinson’s disease drug after reports of hundreds of deaths.

First infant epinephrine injector on market

April 30, 2018

After FDA approved the first epinephrine injection specifically for infants and toddlers last year, the drug is now on the market.

Campaign gears up to combat high drug prices

May 09, 2017

Walmart, CVS Health, and a number of other healthcare organizations are supporting a new multi-million dollar consumer campaign to combat high prescription drug prices.

FDA approves first targeted leukemia drug for certain patients, plus 2 more

May 02, 2017

Late last week, FDA approved a new drug to treat acute myeloid leukemia (AML), the first treatment for Batten disease, and expanded the use of a current drug to treat liver cancer.

New abuse-deterrent opioid available

May 01, 2017

A new abuse-deterrent painkiller - oxycodone hydrochloride (RoxyBond, Inspirion Delivery Services) - will be available soon after receiving FDA approval.

FDA clears second Remicade biosimilar

April 24, 2017

In what is expected to produce hefty saving for rheumatoid arthritis patients and the healthcare system, FDA approved the second biosimilar to Remicade (Johnson & Johnson).